1
|
Costedoat I, Wallaert M, Gaultier A, Vasseur R, Vanhaecke C, Viguier M, Cordelette C, Denoyer A, Ferrier le Bouëdec MC, Coutu A, Lamiaux M, Tran THC, Lacour JP, Elmaleh V, Tetart F, Gueudry J, Tauber M, Giordano-Labadie F, Cassagne M, Nosbaum A, Ouilhon C, Jachiet M, Tadayoni R, Dezoteux F, Staumont-Salle D, Bouleau J, Labalette P, Doan S, Soria A, Mortemousque B, Seneschal J, Barbarot S. Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients. J Eur Acad Dermatol Venereol 2023; 37:1056-1063. [PMID: 36732052 DOI: 10.1111/jdv.18932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Accepted: 01/05/2023] [Indexed: 02/04/2023]
Abstract
BACKGROUND Although ocular adverse events are frequent in AD patients treated with dupilumab, their characterization remains limited due to a lack of prospective studies with a systematic ophthalmological examination. OBJECTIVE To examine the incidence, characteristics and risk factors of dupilumab-induced ocular adverse events. METHODS A prospective, multicenter, and real-life study in adult AD patients treated with dupilumab. RESULTS At baseline, 27 out of 181 patients (14.9%) had conjunctivitis. At week 16 (W16), 25 out of 27 had improved their conjunctivitis and 2 remained stable and 34 out of 181 patients (18.7%) had dupilumab-induced blepharoconjunctivitis: either de novo (n = 32) or worsening of underlying blepharoconjunctivitis (n = 2). Most events (27/34; 79.4%) were moderate. A multivariate analysis showed that head and neck AD (OR = 7.254; 95%CI [1.938-30.07]; p = 0.004), erythroderma (OR = 5.635; 95%CI [1.635-21.50]; p = 0.007) and the presence of dry eye syndrome at baseline (OR = 3.51; 95%CI [3.158-13.90]; p = 0.031) were independent factors associated with dupilumab-induced blepharoconjunctivitis. LIMITATIONS Our follow-up period was 16 weeks and some late-onset time effects may still occur. CONCLUSION This study showed that most dupilumab-induced blepharoconjunctivitis cases are de novo. AD severity and conjunctivitis at baseline were not found to be associated risk factors in this study.
Collapse
Affiliation(s)
- Ingrid Costedoat
- CHU de Bordeaux, National Reference Center for Rare Skin Diseases, CNRS UMR5164, ImmunoConCept, Univ. Bordeaux, Bordeaux, France
| | - Martin Wallaert
- Department of Dermatology and Ophthalmology, CHU Nantes, UMR 1280 PhAN, INRA, Nantes Université, Nantes, France
| | - Aurelie Gaultier
- CHU Nantes, Direction de la recherche, Plateforme de Méthodologie et Biostatistique, Nantes Université, Nantes, France
| | - Robin Vasseur
- Department of Dermatology and Ophthalmology, CHU Nantes, UMR 1280 PhAN, INRA, Nantes Université, Nantes, France
| | - Clelia Vanhaecke
- Department of Dermatology-Venerology, CHU Robert-Debré, Reims, France
| | - Manuelle Viguier
- Department of Dermatology-Venerology, CHU Robert-Debré, Reims, France
| | | | | | | | - Adrien Coutu
- Department of Dermatology-Venerology and Ophthalmology, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France
| | - Marie Lamiaux
- Department of Dermatology-Venerology and Ophthalmology, Lille Catholic Hospital, Lille Catholic University
| | - Thi Ha Châu Tran
- Department of Dermatology-Venerology and Ophthalmology, Lille Catholic Hospital, Lille Catholic University
| | - Jean Philippe Lacour
- Department of Dermatology-Venerology and Ophthalmology, University Hospital of Nice-Côte d'Azur, Nice, France
| | - Valerie Elmaleh
- Department of Dermatology-Venerology and Ophthalmology, University Hospital of Nice-Côte d'Azur, Nice, France
| | - Florence Tetart
- Department of Dermatology-Venerology and Ophthalmology, Rouen University Hospital, Rouen, France
| | - Julie Gueudry
- Department of Dermatology-Venerology and Ophthalmology, Rouen University Hospital, Rouen, France
| | - Marie Tauber
- Department of Dermatology-Venerology and Ophthalmology, Toulouse, France
| | | | - Myriam Cassagne
- Department of Ophthalmology, Toulouse University Hospital, Toulouse, France
| | - Audrey Nosbaum
- Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Service d'Ophtalmologie, Civils de Lyon, Pierre Bénite, France.,CIRI - Centre International de Recherche en Infectiologie (International Center for Infectiology Research), INSERM U1111, CNRS UMR, Univ Lyon, Lyon, France
| | - Coralie Ouilhon
- Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Service d'Ophtalmologie, Civils de Lyon, Pierre Bénite, France.,CIRI - Centre International de Recherche en Infectiologie (International Center for Infectiology Research), INSERM U1111, CNRS UMR, Univ Lyon, Lyon, France
| | - Marie Jachiet
- Faculty of Medicine, Assistance Publique-Hôpitaux de Paris (APHP), Department of Dermatology, Saint-Louis Hospital, University of Paris, Paris, France
| | - Ramin Tadayoni
- Faculty of Medicine, Assistance Publique-Hôpitaux de Paris (APHP), Department of Ophthalmology, Lariboisiere Hospital, University of Paris, Paris, France
| | - Frederic Dezoteux
- Centre de Référence des Syndromes Hyperéosinophiliques, Department of Dermatology-Venerology, CHU Lille, U1286 Inserm INFINITE, Université de Lille, Lille, France
| | - Delphine Staumont-Salle
- Centre de Référence des Syndromes Hyperéosinophiliques, Department of Dermatology-Venerology, CHU Lille, U1286 Inserm INFINITE, Université de Lille, Lille, France
| | - Julien Bouleau
- Department of Ophthalmology, CHU Lille, Univ. Lille, Lille, France
| | - Pierre Labalette
- Department of Ophthalmology, CHU Lille, Univ. Lille, Lille, France
| | - Serge Doan
- Departement of Dermatology-Venerology and Allergology, Hôpital Tenon, Paris HUEP, APHP, Paris, France.,Sorbonne Université, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| | - Angele Soria
- Departement of Dermatology-Venerology and Allergology, Hôpital Tenon, Paris HUEP, APHP, Paris, France.,Sorbonne Université, Paris, France.,Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France
| | - Bruno Mortemousque
- CHU de Bordeaux, National Reference Center for Rare Skin Diseases, CNRS UMR5164, ImmunoConCept, Univ. Bordeaux, Bordeaux, France
| | - Julien Seneschal
- CHU de Bordeaux, National Reference Center for Rare Skin Diseases, CNRS UMR5164, ImmunoConCept, Univ. Bordeaux, Bordeaux, France
| | - Sebastien Barbarot
- Department of Dermatology and Ophthalmology, CHU Nantes, UMR 1280 PhAN, INRA, Nantes Université, Nantes, France
| | | |
Collapse
|
2
|
Destoop JA, Vanhaecke C, Banisadr F, Plenier Y, Viguier M, Hentzien M. Impact des recommandations HAS 2019 sur la durée de l’antibiothérapie des dermo-hypodermites bactériennes non nécrosantes chez l’adulte. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
3
|
Canard C, Molitor A, Gusdorf L, Vanhaecke C, Servettaz A, Georgin-Lavialle S, Durlach A, Touitou I, Sarrabay G, Carapito R, Barham S, Viguier M. Péri-artérite noueuse familiale non liée à un déficit en adénosine déaminase-2. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
4
|
Colas M, Vanhaecke C, Courtieu C, Lambert D, Lihoreau T, Merle C, Guerre-Schmidt A, Ginet-Mermet I, Viguier M, Pelletier F, Aubin F. Étude observationnelle sur l’impact de la prophylaxie pré-exposition de l’infection par le VIH (PrEP) sur les infections sexuellement transmissibles. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
5
|
Colas M, Vanhaecke C, Courtieu C, Lambert D, Lihoreau T, Merle C, Schmidt-Guerre AR, Ginet-Mermet I, Viguier M, Pelletier F, Aubin F. Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men: real-life experience from three sexual health clinics in France. J Eur Acad Dermatol Venereol 2020; 35:e94-e96. [PMID: 32697864 DOI: 10.1111/jdv.16832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- M Colas
- Service de Dermatologie, CHU et UFR Santé, Université de Franche-Comté, Besançon, France
| | - C Vanhaecke
- Service de Dermatologie, CeGIDD, CHU, Reims, France
| | - C Courtieu
- CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France
| | - D Lambert
- Service de Dermatologie, CeGIDD, CHU, Reims, France
| | - T Lihoreau
- Inserm, CIC 1431, Centre d'Investigation Clinique, CHU, Besançon, France
| | - C Merle
- Service de Dermatologie, CHI de Haute-Saône, Vesoul, France
| | - A R Schmidt-Guerre
- CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France
| | - I Ginet-Mermet
- CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France
| | - M Viguier
- Service de Dermatologie, CeGIDD, CHU, Reims, France
| | - F Pelletier
- Service de Dermatologie, CHU et UFR Santé, Université de Franche-Comté, Besançon, France.,CeGIDD - Association d'Hygi'ne Sociale de Franche-Comté, Besançon, France.,INSERM UMR 1098, Université de Franche-Comté, Besançon, France
| | - F Aubin
- Service de Dermatologie, CHU et UFR Santé, Université de Franche-Comté, Besançon, France.,INSERM UMR 1098, Université de Franche-Comté, Besançon, France
| |
Collapse
|
6
|
Clapé A, Muller C, Plée J, Viguier M, Vanhaecke C, Bernard P. Feasibility and healthcare costs of superpotent topical corticosteroid therapy in bullous pemphigoid: a prospective, observational study in an academic centre in France. Br J Dermatol 2020; 183:775-776. [PMID: 32320476 DOI: 10.1111/bjd.19151] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- A Clapé
- Department of Dermatology, Reims University Hospital, Reims, France
| | - C Muller
- Laboratory of Dermatology, Faculty of Medicine of Reims, EA 7509, IFR 53, URCA, Reims, France
| | - J Plée
- Department of Dermatology, Reims University Hospital, Reims, France
| | - M Viguier
- Department of Dermatology, Reims University Hospital, Reims, France.,Laboratory of Dermatology, Faculty of Medicine of Reims, EA 7509, IFR 53, URCA, Reims, France
| | - C Vanhaecke
- Department of Dermatology, Reims University Hospital, Reims, France
| | - P Bernard
- Department of Dermatology, Reims University Hospital, Reims, France.,Laboratory of Dermatology, Faculty of Medicine of Reims, EA 7509, IFR 53, URCA, Reims, France
| |
Collapse
|
7
|
Diaz E, Vanhaecke C, Sanchez J, Durlach A, Gusdorf L, Viguier M. Angiomatose dermique diffuse ulcérée multifocale. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
8
|
Clapé A, Muller C, Antonicelli F, Vanhaecke C, Viguier M, Plée J, Bernard P. Enquête de pratique de la prise en charge de la pemphigoïde bulleuse : place et coût de la dermocorticothérapie forte. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
9
|
Condamina M, Loget J, Le Berruyer PY, Vatin S, Durlach A, Vanhaecke C, Gusdorf L, Diaz E, Viguier MA. Calciphylaxie non urémique après chirurgie bariatrique. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.476] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Chelli C, Loget J, Vanhaecke C, Durlach A, Gagneux Lemoussu L, Soriano C, Viguier M. Vascularite cutanée sévère avec atteinte digestive développée sous sécukinumab. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
11
|
Clapé A, Vanhaecke C, Durlach A, Bernard P, Jouannaud C, Kpodar L, Cribier B, Viguier M. Granulome annulaire interstitiel diffus avec polyarthrite révélant un cancer du sein. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
12
|
Stien S, Vanhaecke C, Durlach A, Bernard P, Battistella M, Viguier M. Granulomatose cutanée révélant un déficit immunitaire combiné avec efficacité spectaculaire de l’étanercept. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
13
|
Larsabal M, Ly S, Sbidian E, Moyal‐Barracco M, Dauendorffer J, Dupin N, Richard M, Chosidow O, Beylot‐Barry M, Abdo I, Acquitter M, Breteque Mignot MA, Amici J, Archier E, Aubin F, Barthelemy H, Baubion E, Beneton N, Bolac C, Bouilly D, Bourseau‐Quetier C, Brenaut E, Buzenet C, Camus M, Celerier P, Chabbert C, Chamaillard M, Charles S, Darrigade A, Delarue M, Depaire F, Devaux S, Do‐Pham G, Duval‐Modeste A, Fabre F, Fauconneau A, Fite C, Fleuret C, Girard C, Grande S, Guillet S, Hacard F, Hegazy S, Hosteing S, Jacquin M, Jegou M, Joly P, Jouary T, Julien D, Kemula M, Kostrzewa E, Lacour J, Legrain V, Livideanu C, Lu D, Maccari F, Magne F, Martin C, Meunier L, Misery L, Parier J, Pelletier F, Perrussel M, Petit‐Fauconneau A, Peyrot I, Plantin P, Pruvost‐Balland C, Regnier E, Reynier‐Rezzi J, Salzes C, Seneschal J, Shollhammer M, Souteyrand A, Staumont D, Toulemonde A, Vanhaecke C, Vedie A, Versapuech J, Vigan M, Viguier M, Villani A. GENIPSO: a French prospective study assessing instantaneous prevalence, clinical features and impact on quality of life of genital psoriasis among patients consulting for psoriasis. Br J Dermatol 2018; 180:647-656. [DOI: 10.1111/bjd.17147] [Citation(s) in RCA: 32] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/31/2018] [Indexed: 12/01/2022]
Affiliation(s)
- M. Larsabal
- Department of Dermatology Bordeaux University Hospital Bordeaux University Bordeaux France
| | - S. Ly
- Department of Dermatology Bordeaux University Hospital Bordeaux University Bordeaux France
- Vulvology Study Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | - E. Sbidian
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Henri‐Mondor Hospital, Public Assistance – Paris Hospitals (AP‐HP) CréteilFrance
- Virus,Immunity and Cancer University‐Hospital Complex (DHU VIC) EA 7379 Epidemiology in Dermatology and Evaluation of Treatments (EpiDermE) Paris‐Est University Créteil (UPEC) CréteilFrance
| | - M. Moyal‐Barracco
- Vulvology Study Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Cochin Tarnier Hospital Paris Descartes University ParisFrance
| | - J.‐N. Dauendorffer
- Vulvology Study Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Saint‐Louis Hospital Paris France
| | - N. Dupin
- Department of Dermatology Cochin Tarnier Hospital Paris Descartes University ParisFrance
- Dermatological Infectiology and Sexually Transmitted Diseases Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | - M.A. Richard
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Timone Hospital, Public Assistance–Marseille Hospitals Aix‐Marseille University UMR 911, INSERM CRO2, “Centre de recherche en oncologie biologique et oncopharmacologie” Marseille France
| | - O. Chosidow
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
- Department of Dermatology Henri‐Mondor Hospital, Public Assistance – Paris Hospitals (AP‐HP) CréteilFrance
- Virus,Immunity and Cancer University‐Hospital Complex (DHU VIC) EA 7379 Epidemiology in Dermatology and Evaluation of Treatments (EpiDermE) Paris‐Est University Créteil (UPEC) CréteilFrance
- Dermatological Infectiology and Sexually Transmitted Diseases Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | - M. Beylot‐Barry
- Department of Dermatology Bordeaux University Hospital Bordeaux University Bordeaux France
- Psoriasis Research Group of the French Society for Dermatology Maison de la Dermatologie Malherbes Paris France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Loget JP, Vanhaecke C, Soibinet P, Fleury C, Durlach A, Bernard P, Viguier M. Cancer de l’ovaire révélé par un tableau cutané de lymphangiome acquis. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
15
|
Lheure-Barbier C, Kramkimel N, Plee J, Franck N, Goldman-Levy G, Vanhaecke C, Dupin N, Aractingi S, Grange F, Guegan S. Mélanomes primitifs localement avancés et inopérables en rémission complète après traitement néoadjuvant par anti-PD1 : 3 cas. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
16
|
Vanhaecke C, Deilhes F, Chanal J, Regnier-Rosencher E, Boitier F, Boulinguez S, Avril MF, Guégan S, Dupin N, Aractingi S, Meyer N, Kramkimel N. BRAF V600 inhibitor discontinuation after complete response in advanced melanoma: a retrospective analysis of 16 patients. Br J Dermatol 2017; 177:e94-e95. [DOI: 10.1111/bjd.15345] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- C. Vanhaecke
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
| | - F. Deilhes
- Service de Dermatologie; Université Paul Sabatier - Toulouse III et Institut Universitaire du Cancer de Toulouse; CHU - LARREY et Oncopole; Toulouse France
| | - J. Chanal
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
- Université Paris Descartes; Paris France
| | - E. Regnier-Rosencher
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
| | - F. Boitier
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
| | - S. Boulinguez
- Service de Dermatologie; Université Paul Sabatier - Toulouse III et Institut Universitaire du Cancer de Toulouse; CHU - LARREY et Oncopole; Toulouse France
| | - M.-F. Avril
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
- Université Paris Descartes; Paris France
| | - S. Guégan
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
- Université Paris Descartes; Paris France
| | - N. Dupin
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
- Université Paris Descartes; Paris France
| | - S. Aractingi
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
- Université Paris Descartes; Paris France
| | - N. Meyer
- Service de Dermatologie; Université Paul Sabatier - Toulouse III et Institut Universitaire du Cancer de Toulouse; CHU - LARREY et Oncopole; Toulouse France
- Inserm UMR 1037 - CRCT; Toulouse France
| | - N. Kramkimel
- Service de Dermatologie; Hôpital Cochin Tarnier; APHP; 89 rue d'Assas 75006 Paris France
| |
Collapse
|
17
|
Hoogewoud F, Frumholtz L, Loubet P, Charlier C, Blanche P, Lebeaux D, Benhaddou N, Sedira N, Coutte L, Vanhaecke C, Launay O, Le Jeunne C, Héron E, Monnet D, Lortholary O, Sahel JA, Dupin N, Brézin A, Errera MH, Salah S, Groh M. Prognostic Factors in Syphilitic Uveitis. Ophthalmology 2017; 124:1808-1816. [PMID: 28779905 DOI: 10.1016/j.ophtha.2017.06.003] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2017] [Revised: 06/02/2017] [Accepted: 06/02/2017] [Indexed: 01/20/2023] Open
Abstract
PURPOSE To identify predictors of treatment success in syphilitic uveitis (SU). DESIGN Retrospective multicentric analysis of patients treated for SU. PARTICIPANTS A total of 95 eyes (66 patients, mean [standard deviation] aged 49 [12.5] years, 31 [47%] of whom were human immunodeficiency virus [HIV]+) were analyzed. METHODS Activity of SU was assessed at 1 week and 1 month after treatment onset, and at last follow-up. Improvement was defined by a ≥2-step decrease of both anterior chamber and vitreous haze inflammation levels, and by the size reduction in chorioretinal lesions. MAIN OUTCOME MEASURES Recovery was defined as the resolution of inflammation in all anatomic structures at 1 month. RESULTS Panuveitis and posterior uveitis were the most frequent findings. Inflammatory parameters were higher in HIV+ patients. Recovery was reported in 65% and 85% of eyes at 1 month and at last follow-up, respectively. In multivariate analysis, after adjusting for initial best-corrected visual acuity and the antimicrobial treatment regimen, clinical improvement at 1 week (corrected risk ratios [cRR], 3.5 [2.3-3.8]; P = 0.001) was predictive of recovery at 1 month, whereas the use of periocular dexamethasone injections (cRR, 0.05 [0.02-0.6]; P = 0.01) and methylprednisolone pulses negatively affected the outcomes of eyes. CONCLUSIONS Early improvement is the strongest predictor of ophthalmological recovery in SU.
Collapse
Affiliation(s)
- Florence Hoogewoud
- Department of Ophthalmology, National Referral Center for Rare Ocular Diseases, Hôpital Cochin, Paris, France
| | - Laure Frumholtz
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France
| | - Paul Loubet
- IAME, UMR 1137, INSERM, Hôpital Bichat, Paris, France; Department of Infectious Diseases, Hôpital Bichat-Claude Bernard, Paris, France
| | - Caroline Charlier
- Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Hôpital Necker Enfants Malades, Paris, France
| | - Philippe Blanche
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France; Department of Infectious Diseases, Hôpital Cochin, Paris, France
| | - David Lebeaux
- Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Hôpital Necker Enfants Malades, Paris, France
| | - Nadjet Benhaddou
- National Referral Center for Syphilis, Hôpital Cochin, APHP, Paris, France
| | - Neila Sedira
- Department of Internal Medicine, Centre Hospitalier National des Quinze-Vingt, Paris, France; DHU ViewMaintain, Sorbonne-Pierre et Marie Curie University, Paris, France
| | - Laetitia Coutte
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France; Department of Infectious Diseases, Hôpital Cochin, Paris, France
| | | | - Odile Launay
- Department of Infectious Diseases, Hôpital Cochin, Paris, France
| | - Claire Le Jeunne
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France
| | - Emmanuel Héron
- Department of Internal Medicine, Centre Hospitalier National des Quinze-Vingt, Paris, France; DHU ViewMaintain, Sorbonne-Pierre et Marie Curie University, Paris, France
| | - Dominique Monnet
- Department of Ophthalmology, National Referral Center for Rare Ocular Diseases, Hôpital Cochin, Paris, France
| | - Olivier Lortholary
- Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Hôpital Necker Enfants Malades, Paris, France
| | - José-Alain Sahel
- Department of Ophthalmology IV, Centre Hospitalier National des Quinze-Vingt, Paris, France; DHU ViewMaintain, Sorbonne-Pierre et Marie Curie University, Paris, France
| | - Nicolas Dupin
- National Referral Center for Syphilis, Hôpital Cochin, APHP, Paris, France; Department of Dermatology, Hôpital Cochin, Paris, France
| | - Antoine Brézin
- Department of Ophthalmology, National Referral Center for Rare Ocular Diseases, Hôpital Cochin, Paris, France
| | - Marie-Hélène Errera
- Department of Ophthalmology IV, Centre Hospitalier National des Quinze-Vingt, Paris, France; DHU ViewMaintain, Sorbonne-Pierre et Marie Curie University, Paris, France
| | - Sawsen Salah
- Department of Ophthalmology, National Referral Center for Rare Ocular Diseases, Hôpital Cochin, Paris, France
| | - Matthieu Groh
- Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Paris, France; Present address: Department of Internal Medicine, Hôpital St. Louis, Paris, France.
| |
Collapse
|
18
|
Vallet H, Gaillet A, Weiss N, Vanhaecke C, Saheb S, Touitou V, Franck N, Kramkimel N, Borden A, Touat M, Ricard D, Verny M, Maisonobe T, Psimaras D. Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma. Ann Oncol 2016; 27:1352-3. [PMID: 26940685 DOI: 10.1093/annonc/mdw126] [Citation(s) in RCA: 58] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Affiliation(s)
- H Vallet
- Geriatric Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, DHU FAST, Assistance Publique Hôpitaux de Paris (APHP), Paris Sorbonne Universités, UPMC Paris 6, UMR CNRS 8256, UMR INSERM 1166, IHU ICAN, DHU FAST, Paris
| | - A Gaillet
- Geriatric Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, DHU FAST, Assistance Publique Hôpitaux de Paris (APHP), Paris
| | - N Weiss
- Neurological Intensive Care Unit, Neurology Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris OncoNeuroTox Group: Center for Investigations of Patients with Neurological Complications after Cancer Treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris
| | - C Vanhaecke
- Department of Dermatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris (APHP), Paris
| | - S Saheb
- Departments of Hemo-biotherapies
| | | | - N Franck
- Department of Dermatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris (APHP), Paris
| | - N Kramkimel
- Department of Dermatology, Hôpital Cochin, Assistance Publique Hôpitaux de Paris (APHP), Paris
| | | | - M Touat
- Neurology 2 (Mazarin), Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris
| | - D Ricard
- OncoNeuroTox Group: Center for Investigations of Patients with Neurological Complications after Cancer Treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris Department of Neurology, Hôpital d'Instruction des Armées du Val-de-Grâce, Service de Santé des Armées, Paris Ecole du Val-de-Grâce, Service de Santé des Armées, Paris UMR 8257 MD4 COGNAC G, CNRS, Service de Santé des Armées, Université Paris-Descartes, Paris
| | - M Verny
- Geriatric Department, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, DHU FAST, Assistance Publique Hôpitaux de Paris (APHP), Paris Sorbonne Universités, UPMC Paris 6, UMR CNRS 8256, UMR INSERM 1166, IHU ICAN, DHU FAST, Paris
| | - T Maisonobe
- Department of Clinical Neurophysiology, Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris
| | - D Psimaras
- OncoNeuroTox Group: Center for Investigations of Patients with Neurological Complications after Cancer Treatment, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix et Val-de-Grâce, Paris Neurology 2 (Mazarin), Hôpitaux universitaires, Pitié-Salpêtrière Charles Foix, Assistance Publique Hôpitaux de Paris (APHP), Paris UMR975 INSERM-UPMC, GH Pitié- Salpêtrière, Paris, France
| |
Collapse
|
19
|
Diaz E, Vanhaecke C, Laurent-Roussel S, Bricaire L, Groussin L, Bertherat J, Bernier M, Jrad G, Grange P, Dupin N. Une hypophysite infectieuse bactérienne bien atypique. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
20
|
Diaz E, Vanhaecke C, Laurent-Roussel S, Kramkimel N, Dupin N, Aractingi S, Franck N, Avril MF. Des poils aux cheveux, description d’un nouveau syndrome paranéoplasique : le TH2PK. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
21
|
Vanhaecke C, Perignon A, Monsel G, Regnier S, Paris L, Caumes E. Aetiologies of creeping eruption: 78 cases. Br J Dermatol 2015; 170:1166-9. [PMID: 24116380 DOI: 10.1111/bjd.12637] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/05/2013] [Indexed: 11/26/2022]
Abstract
BACKGROUND Creeping eruption is a migratory linear cutaneous trail. In addition to hookworm-related cutaneous larva migrans (HrCLM), other diseases can also be revealed by this sign. OBJECTIVES To report the different aetiologies of creeping eruption. METHODS All consecutive patients with creeping eruption presenting to our unit in Pitié Salpêtrière Hospital in Paris between 1 March 2008 and 31 January 2013 were included. The diagnoses were based on microscopic data when available (hookworm folliculitis, strongyloidiasis) or the association of epidemiological, clinical, biological features and good outcome after specific treatment (HrCLM, loiasis, gnathostomiasis). RESULTS Seventy-four patients (95%) presented with HrCLM. All but one had been travelling in a tropical country; seven (9%) also presented with folliculitis. Skin scraping of hookworm folliculitis lesions was performed in five cases and revealed living nematode larvae in three cases. Two patients (3%) with cutaneous gnathostomiasis after returning from Bali and Japan presented with intermittent creeping dermatitis on the foot and thigh, respectively. One patient (1%), native to Cameroon, was diagnosed with loiasis and one patient (1%), with no travel history, presented with 'creeping hair'. CONCLUSION Hookworm-related cutaneous larva migrans explains 95% of the cases of creeping eruption; gnathostomiasis, loiasis and cutaneous pili migrans may also be diagnosed.
Collapse
Affiliation(s)
- C Vanhaecke
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | | | | | | | | | | |
Collapse
|
22
|
Vanhaecke C, Hickman G, Cavelier-Balloy B, Masson V, Duron JB, Gorj M, May P, Schneider P, Vilmer C, Bagot M, Battistella M, Petit A. Plantar keloids: diagnostic and therapeutic issues in six patients. J Eur Acad Dermatol Venereol 2014; 29:1421-6. [PMID: 25088087 DOI: 10.1111/jdv.12625] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2014] [Accepted: 06/06/2014] [Indexed: 11/28/2022]
Abstract
BACKGROUND Keloids are benign fibro-proliferative skin lesions that very rarely occur on the soles. Because of their rarity, the diagnosis of plantar keloids can be difficult. We describe the clinical and histopathological characteristics of eight plantar keloids. METHODS All patients presenting with plantar keloids between 2005 and 2012 in our Dermatology unit were retrospectively included. Diagnosis was definitely established by re-reading of pathological slides in all cases. Clinical characteristics, histopathological features, treatments given and their results were collected. RESULTS Six patients were included. Five patients had a single plantar keloid and one had three lesions. They all were of African descent. Only one patient remembered of a previous injury at the site of the keloid. Three patients presented with associated extra-plantar keloids. In four patients, the diagnosis of keloid was not initially suspected clinically or histologically. Re-reading of the clinical photographs showed that the eight plantar keloids shared common morphological features, leading to a distinctive clinical picture, defined by a hardened lesion of rounded or polycyclic shape, with a pink surface crossed by keratotic furrows and the presence of a hyperkeratotic rim. Concerning pathological features, typical hyalinized collagen can be missing and deep fibrosis should not rule out the diagnosis of keloid. Intralesional injection of triamcinolone acetonide and orthopaedic shoes were useful. All patients who had surgical excision presented recurrence. CONCLUSION The knowledge of the clinical features of plantar keloids is helpful to the diagnosis. There is no well-established treatment, but supportive measures are important.
Collapse
Affiliation(s)
- C Vanhaecke
- Service de Dermatologie, AP- HP Hôpital Saint Louis, Paris, France
| | - G Hickman
- Service de Dermatologie, AP- HP Hôpital Saint Louis, Paris, France
| | - B Cavelier-Balloy
- Service d'Anatomie Pathologique, AP- HP Hôpital Saint Louis, Paris, France
| | - V Masson
- Service de Chirurgie plastique, AP- HP Hôpital Saint Louis, Paris, France
| | - J-B Duron
- Service de Chirurgie plastique, AP- HP Hôpital Saint Louis, Paris, France
| | - M Gorj
- Service de Chirurgie plastique, AP- HP Hôpital Saint Louis, Paris, France
| | - P May
- Service de Chirurgie plastique, AP- HP Hôpital Saint Louis, Paris, France
| | - P Schneider
- Service de Dermatologie, AP- HP Hôpital Saint Louis, Paris, France
| | - C Vilmer
- Service de Dermatologie, AP- HP Hôpital Saint Louis, Paris, France
| | - M Bagot
- Service de Dermatologie, AP- HP Hôpital Saint Louis, Paris, France
| | - M Battistella
- Service d'Anatomie Pathologique, AP- HP Hôpital Saint Louis, Paris, France
| | - A Petit
- Service de Dermatologie, AP- HP Hôpital Saint Louis, Paris, France
| |
Collapse
|
23
|
Vanhaecke C, Grange P, Benhaddou N, Dupin N. Évaluation de la biologie moléculaire dans le LCR pour le diagnostic de neurosyphilis. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.488] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Vanhaecke C, Perignon A, Monsel G, Regnier S, Bricaire F, Caumes E. The efficacy of single dose ivermectin in the treatment of hookworm related cutaneous larva migrans varies depending on the clinical presentation. J Eur Acad Dermatol Venereol 2013; 28:655-7. [DOI: 10.1111/jdv.12097] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2012] [Accepted: 12/17/2012] [Indexed: 11/29/2022]
Affiliation(s)
- C. Vanhaecke
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière; Paris France
| | - A. Perignon
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière; Paris France
| | - G. Monsel
- Service de Dermatologie, Hôpital Saint Louis; Paris Cedex 10 France
| | - S. Regnier
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière; Paris France
| | - F. Bricaire
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière; Paris France
| | - E. Caumes
- Service de Maladies Infectieuses et Tropicales, Hôpital Pitié Salpêtrière; Paris France
| |
Collapse
|
25
|
Vanhaecke C, Vignon-Pennamen MD. [Rosai-Dorfman disease]. Ann Dermatol Venereol 2012. [PMID: 23199779 DOI: 10.1016/j.annder.2012.05.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- C Vanhaecke
- Service de pathologie, hôpital St-Louis, 1, avenue Claude-Vellefaux, 75010 Paris, France
| | | |
Collapse
|
26
|
Vanhaecke C, Perignon A, Monsel G, Regnier S, Bricaire F, Caumes E. Larva migrans cutanée ankylostomiemme chez 63 voyageurs : données épidémiologiques, cliniques, et diagnostiques. Résultats du traitement par ivermectine. Ann Dermatol Venereol 2012. [DOI: 10.1016/j.annder.2012.10.325] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
27
|
|